Eledon Pharmaceuticals, Inc. (ELDN)
2.30
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
2.30
0.00 (0.00%)
After-Hours: 20:00
Eledon Pharmaceuticals Price to Book Value : 5.636 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 5.636 |
| October 22, 2026 | 5.636 |
| October 21, 2026 | 5.538 |
| October 20, 2026 | 5.525 |
| October 19, 2026 | 5.293 |
| October 16, 2026 | 5.219 |
| October 15, 2026 | 5.562 |
| October 14, 2026 | 5.513 |
| October 13, 2026 | 5.734 |
| October 12, 2026 | 5.979 |
| October 09, 2026 | 6.077 |
| October 08, 2026 | 5.930 |
| October 07, 2026 | 5.930 |
| October 06, 2026 | 6.003 |
| October 05, 2026 | 6.126 |
| October 02, 2026 | 6.101 |
| October 01, 2026 | 5.966 |
| September 30, 2026 | 6.199 |
| September 29, 2026 | 6.126 |
| September 28, 2026 | 6.469 |
| September 25, 2026 | 6.493 |
| September 24, 2026 | 6.567 |
| September 23, 2026 | 6.665 |
| September 22, 2026 | 7.081 |
| September 21, 2026 | 6.591 |
| Date | Value |
|---|---|
| September 18, 2026 | 6.420 |
| September 17, 2026 | 6.493 |
| September 16, 2026 | 6.542 |
| September 15, 2026 | 6.640 |
| September 14, 2026 | 6.787 |
| September 11, 2026 | 6.812 |
| September 10, 2026 | 6.812 |
| September 09, 2026 | 6.910 |
| September 08, 2026 | 7.179 |
| September 04, 2026 | 7.400 |
| September 03, 2026 | 7.179 |
| September 02, 2026 | 7.326 |
| September 01, 2026 | 7.375 |
| August 31, 2026 | 7.302 |
| August 28, 2026 | 7.841 |
| August 27, 2026 | 8.135 |
| August 26, 2026 | 8.208 |
| August 25, 2026 | 8.502 |
| August 24, 2026 | 8.355 |
| August 21, 2026 | 8.453 |
| August 20, 2026 | 8.625 |
| August 19, 2026 | 8.698 |
| August 18, 2026 | 8.870 |
| August 17, 2026 | 8.772 |
| August 14, 2026 | 8.674 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| Price | 2.30 |
| Earnings Yield | -43.06% |
| Market Cap | 186.05M |